These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9058529)

  • 21. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
    Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial models of mammalian metabolism: conversion of warfarin to 4'-hydroxywarfarin using Cunninghamella bainieri.
    Rizzo JD; Davis PJ
    J Pharm Sci; 1989 Mar; 78(3):183-9. PubMed ID: 2724074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotransformation of cedrol by Curvularia lunata ATCC 12017.
    Collins DO; Reese PB
    Phytochemistry; 2001 Mar; 56(5):417-21. PubMed ID: 11261573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beauverolides L and La from Beauveria tenella and Paecilomyces fumosoroseus.
    Jegorov A; Sedmera P; Matha V; Simek P; Zahradnícková H; Landa Z; Eyal J
    Phytochemistry; 1994 Nov; 37(5):1301-3. PubMed ID: 7765754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical Methods for Secondary Metabolite Detection.
    Taibon J; Strasser H
    Methods Mol Biol; 2016; 1477():191-209. PubMed ID: 27565501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chiral HPLC analysis of donepezil, 5-O-desmethyl donepezil and 6-O-desmethyl donepezil in culture medium: application to fungal biotransformation studies.
    Barth T; Conti R; Pupo MT; Okano LT; Bonato PS
    Anal Bioanal Chem; 2012 Jul; 404(1):257-66. PubMed ID: 22644152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin.
    Kaminsky LS; Dunbar DA; Wang PP; Beaune P; Larrey D; Guengerich FP; Schnellmann RG; Sipes IG
    Drug Metab Dispos; 1984; 12(4):470-7. PubMed ID: 6148215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection.
    Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K
    Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
    Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH
    J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.
    Locatelli I; Kmetec V; Mrhar A; Grabnar I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):191-8. PubMed ID: 15734158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial hydroxylation of 13-ethyl-17 beta-hydroxy-18,19-dinor-17 alpha-pregn-4-en-20-yn-3-one.
    Hu SH; Tian XF; Sun YH; Han GD
    Steroids; 1996 Jul; 61(7):407-10. PubMed ID: 8837292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of papaverine and in silico docking studies of the metabolites on human phosphodiesterase 10a.
    Eliwa D; Albadry MA; Ibrahim AS; Kabbash A; Meepagala K; Khan IA; El-Aasr M; Ross SA
    Phytochemistry; 2021 Mar; 183():112598. PubMed ID: 33360527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses.
    Kobayashi S; Ishii K; Yamada Y; Ryu E; Hashizume J; Nose S; Hara T; Nakashima M; Ohyama K
    J Thromb Thrombolysis; 2019 Apr; 47(3):467-472. PubMed ID: 30465164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial conversion products of leptomycin B.
    Kuhnt M; Bitsch F; Ponelle M; Sanglier JJ; Wang Y; Wolff B
    Appl Environ Microbiol; 1998 Feb; 64(2):714-20. PubMed ID: 9464413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of cinoxacin by Beauveria bassiana.
    Parshikov IA; Moody JD; Heinze TM; Freeman JP; Williams AJ; Sutherland JB
    FEMS Microbiol Lett; 2002 Aug; 214(1):133-6. PubMed ID: 12204384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. V. Minor metabolites.
    Blows WM; Foster G; Lane SJ; Noble D; Piercey JE; Sidebottom PJ; Webb G
    J Antibiot (Tokyo); 1994 Jul; 47(7):740-54. PubMed ID: 8071119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure elucidation and thermospray high-performance liquid chromatography/mass spectroscopy (HPLC/MS) of the microbial and mammalian metabolites of the antimalarial arteether.
    Hufford CD; Lee IS; ElSohly HN; Chi HT; Baker JK
    Pharm Res; 1990 Sep; 7(9):923-7. PubMed ID: 2235891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
    Pohl LR; Bales R; Trager WF
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.
    Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B
    Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.
    Bryk A; Wypasek E; Awsiuk M; Maj D; Undas A
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):257-64. PubMed ID: 25986145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.